Quick Answer
LISATA THERAPEUTICS, INC. reported Operating Income of -$18.21 million for fiscal year 2025.
LISATA THERAPEUTICS, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$18.21M | +18.7% |
| 2024 | -$22.41M | +12.8% |
| 2023 | -$25.71M | +55.4% |
| 2022 | -$57.60M | -98.3% |
| 2021 | -$29.05M | -51.7% |
| 2020 | -$19.14M | +4.7% |
| 2019 | -$20.09M | -18.3% |
| 2018 | -$16.99M | +38.4% |
| 2017 | -$27.59M | +6.5% |
| 2016 | -$29.50M | +74.1% |
| 2015 | -$113.85M | -97.2% |
| 2014 | -$57.74M | -56.9% |
| 2013 | -$36.81M | -21.1% |
| 2012 | -$30.39M | +10.6% |
| 2011 | -$34.00M | -80.1% |
| 2010 | -$18.88M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$4.41M | +17.3% | +9.3% |
| June 30, 2025 | -$4.87M | +11.9% | +16.7% |
| March 31, 2025 | -$5.85M | +11.4% | -9.6% |
| September 30, 2024 | -$5.34M | +10.5% | +3.4% |
| June 30, 2024 | -$5.52M | +19.7% | +16.3% |
| March 31, 2024 | -$6.60M | +3.6% | -10.7% |
| September 30, 2023 | -$5.96M | +84.2% | +13.3% |
| June 30, 2023 | -$6.88M | -2.3% | -0.5% |
- LISATA THERAPEUTICS, INC. showed an increase of +18.7% in Operating Income compared to the prior fiscal year.
- Over the 2010–2025 period, LISATA THERAPEUTICS, INC.’s operating income has grown by 3.5% (from -$18.88 million to -$18.21 million).
- The most recent figure is from LISATA THERAPEUTICS, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: